ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

39.26
Delayed Data
As of Mar 05
 +1.12 / +2.94%
Today’s Change
15.64
Today|||52-Week Range
40.25
+23.65%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 42.00, with a high estimate of 50.00 and a low estimate of 33.00. The median estimate represents a +6.98% increase from the last price of 39.26.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$375.0K
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.43%
 
 
 
 
 
 
Growthannually 19.58%
 
 
 
 
 
 

Sales

Growthquarterly 697.87%
 
 
 
 
 
 
Growthannually 816.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account